BTX - BioTime, Inc.

NYSE American - NYSE American Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5151.14M
Enterprise Value 3127.53M
Trailing P/E 2.28
Forward P/E 1-4.39
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)28.98
Price/Book (mrq)0.93
Enterprise Value/Revenue 324.45
Enterprise Value/EBITDA 6-3.43

Trading Information

Stock Price History

Beta (3Y Monthly) 3.45
52-Week Change 3-47.78%
S&P500 52-Week Change 37.40%
52 Week High 32.8100
52 Week Low 30.6600
50-Day Moving Average 31.0711
200-Day Moving Average 31.1826

Share Statistics

Avg Vol (3 month) 3553.17k
Avg Vol (10 day) 3282.2k
Shares Outstanding 5126.96M
Float 107.59M
% Held by Insiders 15.79%
% Held by Institutions 140.92%
Shares Short (Jun 14, 2019) 410.1M
Short Ratio (Jun 14, 2019) 419.41
Short % of Float (Jun 14, 2019) 49.44%
Short % of Shares Outstanding (Jun 14, 2019) 46.75%
Shares Short (prior month May 15, 2019) 410.87M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 21/3
Last Split Date 3Oct 31, 1997

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Mar 31, 2019

Profitability

Profit Margin 1,090.47%
Operating Margin (ttm)-774.09%

Management Effectiveness

Return on Assets (ttm)-17.16%
Return on Equity (ttm)42.63%

Income Statement

Revenue (ttm)5.21M
Revenue Per Share (ttm)0.04
Quarterly Revenue Growth (yoy)32.40%
Gross Profit (ttm)4.69M
EBITDA -37.2M
Net Income Avi to Common (ttm)56.87M
Diluted EPS (ttm)0.4430
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)27.1M
Total Cash Per Share (mrq)0.18
Total Debt (mrq)5.09M
Total Debt/Equity (mrq)3.16
Current Ratio (mrq)3.51
Book Value Per Share (mrq)1.09

Cash Flow Statement

Operating Cash Flow (ttm)-29.86M
Levered Free Cash Flow (ttm)-15.3M